Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
316M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
97.9M
-
Shares change
-
-219K
-
Total reported value, excl. options
-
$311M
-
Value change
-
-$2.01M
-
Put/Call ratio
-
0.73
-
Number of buys
-
57
-
Number of sells
-
-65
-
Price
-
$3.18
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2022
161 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q2 2022.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97.9M shares
of 316M outstanding shares and own 30.97% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21.5M shares), TPG GP A, LLC (16.2M shares), VANGUARD GROUP INC (12.7M shares), BlackRock Inc. (7.46M shares), Eversept Partners, LP (5.49M shares), Point72 Asset Management, L.P. (3.46M shares), Neuberger Berman Group LLC (3.23M shares), STATE STREET CORP (2.61M shares), DIMENSIONAL FUND ADVISORS LP (1.81M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.73M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.